Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Rituximab As a Maintenance Treatment in Patients With Pemphigus Vulgaris: When Is the Right Time for Discontinuation? Publisher Pubmed



Aryanian Z1, 2, 3 ; Balighi K1, 2 ; Emadi SN1, 2 ; Hatami P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Dermatology, Babol University of Medical Sciences, Babol, Iran

Source: Journal of Cosmetic Dermatology Published:2024


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Two Asymptomatic Facial Erythematous Macules in an Adult Male, Skin Health and Disease (2023)
2. A 10-Year Survey on Lichen Planus Pemphigoides in Iran: A Therapeutic Conundrum, Dermatologic Therapy (2022)
3. Two Decades Rituximab Therapy in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis, Current Drug Targets (2025)
4. Epidemiology, Clinical Presentation, and Management of Pemphigoid Nodularis: An Update From Iran, Dermatologic Therapy (2022)
5. What Is Novel in the Clinical Management of Pemphigus Vulgaris?, Expert Review of Clinical Pharmacology (2024)
6. Prevalence and Management of Chronic Hepatitis B in Pemphigus and Pemphigoid Patients: New Evidence for the Safety of Rituximab, Dermatologic Therapy (2022)
7. Impact of Rituximab on Igg and Igm Levels in Patients With Autoimmune Bullous Diseases: A Cohort Study, Archives of Dermatological Research (2025)
8. Sars-Cov-2 Vaccination and Practical Points in Psoriasis Patients: A Narrative Review, Dermatologic Therapy (2022)
Experts (# of related papers)
View all Related Experts
Kamran Balighi (12)
Zeinab Aryanian (10)
Other Related Docs
9. Covid Outcome in Pemphigus: Does Rituximab Make Pemphigus Patients Susceptible to More Severe Covid-19?, Journal of Cosmetic Dermatology (2023)
10. A Case Report of Esophageal Cancer in a Patient With Pemphigus Vulgaris: A Coincidence or Something Beyond That?, Cancer Reports (2023)
11. Kaposi's Sarcoma in a Patient With Pemphigus Vulgaris Mimicking Exacerbation of Pemphigus, Cancer Reports (2023)
12. Comparative Analysis of Demographics and Clinical Outcomes in Patients With Pemphigus Vulgaris and Foliaceus With High Versus Normal Anti-Desmoglein Levels Post-Complete Remission, Archives of Dermatological Research (2025)
13. Dexamethasone or Prednisone: Which One Should Be the Corticosteroid of Choice in Patients With Pemphigus Vulgaris?, Dermatologic Therapy (2022)
14. Rituximab in Practice: Clinical Evaluation of Patients With Pemphigus After Rituximab Administration, Dermatologic Therapy (2021)